Sign up to save your podcasts
Or
Share Episode 36: ODAC - Our Decisions Are Confusing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 36: ODAC - Our Decisions Are Confusing
In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on the STARGLO (glofitamab + GemOx) and AQUILA (daratumumab for smoldering multiple myeloma) trials. Did ODAC do their due diligence, or are there double standards? There is a lot to unpack in this episode!
View all episodes
By Bernard Marini, Anthony Perissinotti, et al.
4.5
3030 ratings
In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on the STARGLO (glofitamab + GemOx) and AQUILA (daratumumab for smoldering multiple myeloma) trials. Did ODAC do their due diligence, or are there double standards? There is a lot to unpack in this episode!
More shows like WolverHeme Happy Hour
View all
Fresh Air
38,482 Listeners
The NPR Politics Podcast
26,040 Listeners
Pod Save America
88,023 Listeners
The Daily
113,446 Listeners
Up First from NPR
56,951 Listeners
OncoPharm
187 Listeners
Today, Explained
10,331 Listeners
Interesting Times with Ross Douthat
7,237 Listeners
Blood Podcast
53 Listeners
ASTCT Talks
8 Listeners
The Ezra Klein Show
16,543 Listeners
The Weekly Show with Jon Stewart
10,983 Listeners
Blood Cancer Talks
51 Listeners
Two Onc Docs
196 Listeners
The Headlines
737 Listeners